Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00648375 · ClinicalTrials.gov registry record · Phase 4
Effectiveness of Propranolol For Treating People With Post-Traumatic Stress Disorder
A Phase 4 study, sponsored by Weill Medical College of Cornell University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT00648375 is a Phase 4 study that was terminated before completion, run by Weill Medical College of Cornell University. The registered enrollment target is 12 participants.
The verdict
NCT00648375, a Phase 4 study, was terminated before completion, sponsored by Weill Medical College of Cornell University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study will evaluate the effectiveness of propranolol in reducing symptoms of distress in people with post-traumatic stress disorder.
Interventions
- DRUG Placebo
- DRUG Propanolol
- BEHAVIORAL Cognitive therapy workbook
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2003-12 |
| Est. Completion | 2009-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00648375
The ClinicalTrials.gov registry entry for NCT00648375 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00648375 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00648375 about?
NCT00648375 is a clinical study titled "Effectiveness of Propranolol For Treating People With Post-Traumatic Stress Disorder". This study will evaluate the effectiveness of propranolol in reducing symptoms of distress in people with post-traumatic stress disorder.
What is the current status of trial NCT00648375?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2003-12. Estimated completion is 2009-09.
What interventions are being tested in trial NCT00648375?
The interventions under investigation include: Placebo (DRUG), Propanolol (DRUG), Cognitive therapy workbook (BEHAVIORAL).
Who is sponsoring clinical trial NCT00648375?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.